A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Combinations of Inhibitors of Influenza Virus Replication
Assignee: Cocrystal Pharma, Inc.Patent Number: US 12233066 B2Filed: October 17, 2019Issued: February 25, 2025Inventors: Irina C. Jacobson, Biing Yuan Lin, Sam S.K. Lee What This Patent Covers This patent protects specific combinations of antiviral compounds that work together to inhibit replication…
-
TIGR-Tas: A family of modular RNA-guided DNA-targeting systems in prokaryotes and their viruses
Published in Science (February 27, 2025) — a landmark paper that describes a new class of programmable genome-editing tools beyond CRISPR. For nearly a decade, CRISPR-Cas systems have dominated the genome editing landscape. However, CRISPR…
-
Extended release upadacitinib formulations
US20250161302A1 (continuation of extended release upadacitinib formulations)Filing Date: January 17, 2025 Priority Date: December 29, 2020 What This Patent Covers This patent family protects extended-release formulations of upadacitinib, the active small molecule in Rinvoq, AbbVie’s…
BioTech IP Review 